EMT-mechanizm induces the leukemic stemness phenotype in myeloid leukemias

  • L. P. Shvachko
DOI: https://doi.org/10.7124/FEEO.v23.1024

Abstract

Aim. To study the targeted expression EMT-induced markers N-cadherin, Snail and Twist in patients with the chronic and acute myeloid leukemias. Methods. RT-PCR, electroforesic in agarose gel, TotalLab v. 2.01 densitometry. Results. Have been investigated the relative levels of mRNA expression of N-cadherin and transcriptional factors Snail and Twist, associated with epithelial-to-mesenchymal induction (EMT) in patients with the essential polycytemia (EP), the chronic mieloid leukemia CML), the acute myeloid leukemia (AML) and the acute lymphoblastic leukemia (ALL). Conclusions. Have been highlighted the EMT stemness mechanism in Leukemic stem cell progression.

Keywords: the epithelial-to-mesencymal transition (EMT), EMT-inducer marker, N-cadherin, Snail, Twist, myeloid leukemias, leuklemic stem cell progression.

References

Reya T., Morrison S.J. Stem cells, cancer, and cancer stem cells. Nature. 2001. Vol. 414. P. 105–111. doi: 10.1038/35102167

Thiery J. Epithelial-mesenchymal transition in tumor progression. Nature Reviews Cancer. 2002. Vol. 2. P. 442–454. doi: 10.1038/nrc822

Kalluri R., Weinberg R.A. The basics of epithelial–mesenchymal transition. J. Clin. Invest. 2009. Vol. 119. P. 1420– 1428. doi: 10.1172/JCI39104.

Ye X., Weinberg R.A. Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. Trends Cell Biol. 2015. Vol. 25. P. 675–686. doi: 10.1016/j.tcb.2015.07.012.

Mani S.A, Guo W., Liao M.J. et.al. The EMT generates cells with properties of stem cells. Cell. 2008. Vol. 133. P. 704–715. doi: 10.1016/j.cell.2008.03.027.

Singh A., Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010. Vol. 29. P. 4741–4751. doi: 10.1038/onc.2010.215

Jung H.Y., Yang J. Unraveling the TWIST between EMT and cancer stemness. Cell Stem Cell. 2015. Vol. 16. P. 1–2. doi: 10.1016/j.stem.2014.12.005.

Tsuji T., Ibaragi S., Hu G.F. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 2009. Vol. 69. P. 7135–139. doi: 10.1158/0008-5472.CAN-09-1618

Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 1998. Vol. 153. P. 333–339. doi: 10.1016/S0002-9440(10)65575-7

Melki J.R., Vincent P.C., Brown R.D. et. al. Hypermethylation of E-cadherin in leukemia. Blood. 2000. Vol. 95. P. 3208–3213.

Shvachko L.P., Holod O.V. The epithelial-to-methenchymal transformation in carcinogenesis. Oncologia. 2014. Vol. 16. P. 4–12 (Ukrainian).

Lamouille S., Xu J., Derynck D. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 2014. Vol. 15. P. 178–196. doi: 10.1038/nrm3758.

Hazan R.B., Qiao R., Keren R., Badano I., Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci. 2004. Vol. 1014. P. 155–163. doi: 10.1196/annals.1294.016

Gravdal K., Halvorsen1 O.J., Haukaas S.A., Akslen L.A. A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer. Clin Cancer Res. 2007. Vol. 13. P. 7003. doi: 10.1158/1078-0432.CCR-07-1263

Micalizzi D.S, Farabaugh S.M. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. Gland Biol Neoplasia. 2010. Vol. 15. P. 117–134. doi: 10.1007/s10911-010-9178-9

Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006. Vol. 7. P. 131–142. doi: 10.1038/nrm1835

Nelson W.J, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science. 2004. Vol. 5. P. 1483–1487. doi: 10.1126/science.1094291

Sun L., Fang J. Epigenetic regulation of epithelial‐mesenchymal transition. Cell Mol Life Sci. 2016. Vol. 73. P. 4493–4515. doi: 10.2174/15680096113136660103

Dang H., Ding W., Emerson D. et. al. Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics. BMC Cancer. 2011. Vol. 11. P. 1–13. doi: 10.1186/1471-2407-11-396.

Yang J., Mani S.A., Donaher J.L. et. al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004. Vol. 117. P. 927–939. doi: 10.1016/j.cell.2004.06.006

Chin J-H., Tang J-L., Chen R-L., Li Ch-Ch., Lee Ch.P. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy. Leukemia Res. 2008. Vol. 32. P. 1724–1734. doi: 10.1016/j.leukres.2008.04.023

Soverinia S., Branford S., Nicolinie F.E., Talpaz M., Deininger M.W.N., Martinelli G., Muller M.C., Radich J.P., Shahj N.P. Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia. Leukemia Res. 2014. Vol. 38. P. 10–20. doi: 10.1016/j.leukres.2013.09.011